Literature DB >> 7558123

Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.

R Arnold1, B König, H Galatti, H Werchau, W König.   

Abstract

During the initial phase of respiratory syncytial virus (RSV) infection, when a low virus-cell ratio is most probable, signs of inflammation are detectable in the infected respiratory tissue. Therefore we analysed the release of the proinflammatory cytokines interleukin-6 (IL-6), IL-8, tumour necrosis factor-alpha (TNF-alpha), and the soluble form of the TNF receptor-I (sTNFR-I), from peripheral blood mononuclear cells (PBMC) after exposure to low infectious RSV doses (multiplicity of infection, MOI, 0.001-1) and incubation times of up to 24 hr. The PBMC secreted IL-8 in a time- and virus dose-dependent fashion. As was verified by Northern blot analysis, the increased IL-8 secretion rate was accompanied by an enhanced IL-8 mRNA steady-state level. The infection of the PBMC after 4 hr post-RSV exposure was verified by detection of RSVSH genomic RNA and mRNA after reverse transcription and polymerase chain reaction (PCR) amplification. In addition, after 24 hr post-infection we determined the percentage of infected cells by specific immunofluorescence using monoclonal antibodies directed against the F- and G-proteins. After exposure of PBMC to inactivated RSV, we observed only RSVSH genomic RNA and a reduced IL-8 release. Thus, even the binding and/or phagocytosis of RSV by PBMC induced an IL-8 synthesis to some extent. Following an incubation time of 24 hr, PBMC exposed to small RSV doses synthesized and released high amounts of IL-6 into the cell supernatant. In contrast, only low amounts of TNF-alpha were released from PBMC. In addition to the release of the proinflammatory cytokines, an enhanced level of the sTNFR-I was measured in the cell supernatants at a MOI of 0.1. However, there was no correlation between TNFR-I membrane expression and cell supernatant concentration. Co-culture experiments performed with PBMC and human epithelial cells (A549) revealed that the enhanced IL-8 secretion profile observed in the coculture was partially dependent on the cytokines TNF-alpha, IL-1 beta and TNF-beta/lymphotoxin released by the cells themselves.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558123      PMCID: PMC1383908     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

1.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

Authors:  R H Parrott; H W Kim; J O Arrobio; D S Hodes; B R Murphy; C D Brandt; E Camargo; R M Chanock
Journal:  Am J Epidemiol       Date:  1973-10       Impact factor: 4.897

2.  A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 3.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

4.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

5.  Defective interfering particles of respiratory syncytial virus.

Authors:  M W Treuhaft; M O Beem
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  The stabilization and purification of respiratory syncytial virus using MgSO4.

Authors:  B F Fernie; J L Gerin
Journal:  Virology       Date:  1980-10-15       Impact factor: 3.616

8.  A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.

Authors:  M Lieber; B Smith; A Szakal; W Nelson-Rees; G Todaro
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

9.  Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies.

Authors:  W J Hall; C B Hall; D M Speers
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

10.  Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill.

Authors:  U Mathur; D W Bentley; C B Hall
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

View more
  10 in total

1.  Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro.

Authors:  T L Gower; B S Graham
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection.

Authors:  L H Thomas; M I Wickremasinghe; M Sharland; J S Friedland
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection.

Authors:  D Gentile; W Doyle; T Whiteside; P Fireman; F G Hayden; D Skoner
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

4.  Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells.

Authors:  Shirin Munir; Cyril Le Nouen; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow.

Authors:  Kimberly D Dyer; Jennifer M Moser; Meggan Czapiga; Steven J Siegel; Caroline M Percopo; Helene F Rosenberg
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity.

Authors:  Marina S Boukhvalova; Gregory A Prince; Jorge C G Blanco
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

7.  Antiviral activity of ginseng extract against respiratory syncytial virus infection.

Authors:  Jong Seok Lee; Eun-Ju Ko; Hye Suk Hwang; Yu-Na Lee; Young-Man Kwon; Min-Chul Kim; Sang-Moo Kang
Journal:  Int J Mol Med       Date:  2014-04-22       Impact factor: 4.101

Review 8.  The role of respiratory viruses in acute and chronic asthma.

Authors:  A Tuffaha; J E Gern; R F Lemanske
Journal:  Clin Chest Med       Date:  2000-06       Impact factor: 2.878

9.  Single TNFalpha trimers mediating NF-kappaB activation: stochastic robustness of NF-kappaB signaling.

Authors:  Tomasz Lipniacki; Krzysztof Puszynski; Pawel Paszek; Allan R Brasier; Marek Kimmel
Journal:  BMC Bioinformatics       Date:  2007-10-09       Impact factor: 3.169

10.  Cytokine secretion responsiveness of lymphomonocytes following cortisol cell exposure: Sex differences.

Authors:  Eleonora Da Pozzo; Chiara Giacomelli; Chiara Cavallini; Claudia Martini
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.